10 | | - | SECTION 1. Section 481.076, Health and Safety Code, is |
---|
| 19 | + | SECTION 1. Subchapter C, Chapter 481, Health and Safety |
---|
| 20 | + | Code, is amended by adding Section 481.0755 to read as follows: |
---|
| 21 | + | Sec. 481.0755. WRITTEN, ORAL, AND TELEPHONICALLY |
---|
| 22 | + | COMMUNICATED PRESCRIPTIONS. (a) Notwithstanding Sections |
---|
| 23 | + | 481.073, 481.074, and 481.075, a person prescribing or dispensing a |
---|
| 24 | + | controlled substance must use the electronic prescription record |
---|
| 25 | + | and may not use a written, oral, or telephonically communicated |
---|
| 26 | + | prescription. |
---|
| 27 | + | (b) A prescriber may issue a written, oral, or |
---|
| 28 | + | telephonically communicated prescription for a controlled |
---|
| 29 | + | substance as authorized under this subchapter only if the |
---|
| 30 | + | prescription is issued: |
---|
| 31 | + | (1) by a veterinarian; |
---|
| 32 | + | (2) in circumstances in which electronic prescribing |
---|
| 33 | + | is not available due to temporary technological or electronic |
---|
| 34 | + | failure, as prescribed by board rule; |
---|
| 35 | + | (3) by a practitioner to be dispensed by a pharmacy |
---|
| 36 | + | located outside this state, as prescribed by board rule; |
---|
| 37 | + | (4) when the prescriber and dispenser are the same |
---|
| 38 | + | entity; |
---|
| 39 | + | (5) in circumstances in which necessary elements are |
---|
| 40 | + | not supported by the most recent electronic prescription drug |
---|
| 41 | + | software; |
---|
| 42 | + | (6) for a drug for which the United States Food and |
---|
| 43 | + | Drug Administration requires additional information in the |
---|
| 44 | + | prescription that is not possible with electronic prescribing; |
---|
| 45 | + | (7) for a non-patient-specific prescription pursuant |
---|
| 46 | + | to a standing order, approved protocol for drug therapy, |
---|
| 47 | + | collaborative drug management, or comprehensive medication |
---|
| 48 | + | management, in response to a public health emergency or in other |
---|
| 49 | + | circumstances in which the practitioner may issue a |
---|
| 50 | + | non-patient-specific prescription; |
---|
| 51 | + | (8) for a drug under a research protocol; |
---|
| 52 | + | (9) by a prescriber who is employed by or is practicing |
---|
| 53 | + | a health care profession at a health-related institution, as |
---|
| 54 | + | defined by Section 62.161, Education Code, as added by Chapter 448 |
---|
| 55 | + | (H.B. 7), Acts of the 84th Legislature, 2015; |
---|
| 56 | + | (10) by a practitioner who has received a waiver under |
---|
| 57 | + | Subsection (c) from the requirement to use electronic prescribing; |
---|
| 58 | + | or |
---|
| 59 | + | (11) under circumstances in which the practitioner has |
---|
| 60 | + | the present ability to submit an electronic prescription but |
---|
| 61 | + | reasonably determines that it would be impractical for the patient |
---|
| 62 | + | to obtain the drugs prescribed under the electronic prescription in |
---|
| 63 | + | a timely manner and that a delay would adversely impact the |
---|
| 64 | + | patient's medical condition. |
---|
| 65 | + | (c) The board shall adopt rules establishing a process by |
---|
| 66 | + | which a practitioner may request and receive a waiver under |
---|
| 67 | + | Subsection (b)(10), not to exceed one year, from the requirement to |
---|
| 68 | + | use electronic prescribing. The board shall adopt rules |
---|
| 69 | + | establishing the eligibility for a waiver, including: |
---|
| 70 | + | (1) economic hardship; |
---|
| 71 | + | (2) technological limitations not reasonably within |
---|
| 72 | + | the control of the practitioner; or |
---|
| 73 | + | (3) other exceptional circumstances demonstrated by |
---|
| 74 | + | the practitioner. |
---|
| 75 | + | (d) A written, oral, or telephonically communicated |
---|
| 76 | + | prescription must comply with the applicable requirements |
---|
| 77 | + | prescribed by Sections 481.074 and 481.075. |
---|
| 78 | + | (e) A dispensing pharmacist who receives a controlled |
---|
| 79 | + | substance prescription in a manner other than electronically is not |
---|
| 80 | + | required to verify that the prescription is exempt from the |
---|
| 81 | + | requirement that it be submitted electronically. |
---|
| 82 | + | (f) The board shall enforce this section. |
---|
| 83 | + | SECTION 2. Section 481.076, Health and Safety Code, is |
---|
11 | 84 | | amended by amending Subsections (a), (f), (g), and (h) and adding |
---|
12 | 85 | | Subsection (a-6) to read as follows: |
---|
13 | 86 | | (a) The board may not permit any person to have access to |
---|
14 | 87 | | information submitted to the board under Section 481.074(q) or |
---|
15 | 88 | | 481.075 except: |
---|
16 | 89 | | (1) the board, the Texas Medical Board, the Texas |
---|
17 | 90 | | Department of Licensing and Regulation, with respect to the |
---|
18 | 91 | | regulation of podiatrists [State Board of Podiatric Medical |
---|
19 | 92 | | Examiners], the State Board of Dental Examiners, the State Board of |
---|
20 | 93 | | Veterinary Medical Examiners, the Texas Board of Nursing, or the |
---|
21 | 94 | | Texas Optometry Board for the purpose of: |
---|
22 | 95 | | (A) investigating a specific license holder; or |
---|
23 | 96 | | (B) monitoring for potentially harmful |
---|
24 | 97 | | prescribing or dispensing patterns or practices under Section |
---|
25 | 98 | | 481.0762; |
---|
26 | 99 | | (2) an [authorized officer or member of the department |
---|
27 | 100 | | or] authorized employee of the board engaged in the administration, |
---|
28 | 101 | | investigation, or enforcement of this chapter or another law |
---|
29 | 102 | | governing illicit drugs in this state or another state; |
---|
30 | 103 | | (3) the department or other [on behalf of a] law |
---|
31 | 104 | | enforcement or prosecutorial official engaged in the |
---|
32 | 105 | | administration, investigation, or enforcement of this chapter or |
---|
33 | 106 | | another law governing illicit drugs in this state or another state, |
---|
34 | 107 | | if the board is provided a warrant, subpoena, or other court order |
---|
35 | 108 | | compelling the disclosure; |
---|
36 | 109 | | (4) a medical examiner conducting an investigation; |
---|
37 | 110 | | (5) provided that accessing the information is |
---|
38 | 111 | | authorized under the Health Insurance Portability and |
---|
39 | 112 | | Accountability Act of 1996 (Pub. L. No. 104-191) and regulations |
---|
40 | 113 | | adopted under that Act: |
---|
41 | 114 | | (A) a pharmacist or a pharmacy technician, as |
---|
42 | 115 | | defined by Section 551.003, Occupations Code, acting at the |
---|
43 | 116 | | direction of a pharmacist; or |
---|
44 | 117 | | (B) a practitioner who: |
---|
45 | 118 | | (i) is a physician, dentist, veterinarian, |
---|
46 | 119 | | podiatrist, optometrist, or advanced practice nurse or is a |
---|
47 | 120 | | physician assistant described by Section 481.002(39)(D) or an |
---|
48 | 121 | | employee or other agent of a practitioner acting at the direction of |
---|
49 | 122 | | a practitioner; and |
---|
50 | 123 | | (ii) is inquiring about a recent Schedule |
---|
51 | 124 | | II, III, IV, or V prescription history of a particular patient of |
---|
52 | 125 | | the practitioner; |
---|
53 | 126 | | (6) a pharmacist or practitioner who is inquiring |
---|
54 | 127 | | about the person's own dispensing or prescribing activity; [or] |
---|
55 | 128 | | (7) one or more states or an association of states with |
---|
56 | 129 | | which the board has an interoperability agreement, as provided by |
---|
57 | 130 | | Subsection (j); |
---|
58 | 131 | | (8) a health care facility certified by the federal |
---|
59 | 132 | | Centers for Medicare and Medicaid Services; or |
---|
60 | 133 | | (9) the patient, the patient's parent or legal |
---|
61 | 134 | | guardian, if the patient is a minor, or the patient's legal |
---|
62 | 135 | | guardian, if the patient is an incapacitated person, as defined by |
---|
63 | 136 | | Section 1002.017(2), Estates Code, inquiring about the patient's |
---|
64 | 137 | | prescription record, including persons who have accessed that |
---|
65 | 138 | | record. |
---|
66 | 139 | | (a-6) A patient, the patient's parent or legal guardian, if |
---|
67 | 140 | | the patient is a minor, or the patient's legal guardian, if the |
---|
68 | 141 | | patient is an incapacitated person, as defined by Section |
---|
69 | 142 | | 1002.017(2), Estates Code, is entitled to a copy of the patient's |
---|
70 | 143 | | prescription record as provided by Subsection (a)(9), including a |
---|
71 | 144 | | list of persons who have accessed that record, if a completed |
---|
72 | 145 | | patient data request form and any supporting documentation required |
---|
73 | 146 | | by the board is submitted to the board. The board may charge a |
---|
74 | 147 | | reasonable fee for providing the copy. The board shall adopt rules |
---|
75 | 148 | | to implement this subsection, including rules prescribing the |
---|
76 | 149 | | patient data request form, listing the documentation required for |
---|
77 | 150 | | receiving a copy of the prescription record, and setting the fee. |
---|
78 | 151 | | (f) If the board accesses [director permits access to] |
---|
79 | 152 | | information under Subsection (a)(2) relating to a person licensed |
---|
80 | 153 | | or regulated by an agency listed in Subsection (a)(1), the board |
---|
81 | 154 | | [director] shall notify and cooperate with that agency regarding |
---|
82 | 155 | | the disposition of the matter before taking action against the |
---|
83 | 156 | | person, unless the board [director] determines that notification is |
---|
84 | 157 | | reasonably likely to interfere with an administrative or criminal |
---|
85 | 158 | | investigation or prosecution. |
---|
86 | 159 | | (g) If the board provides [director permits] access to |
---|
87 | 160 | | information under Subsection (a)(3) relating to a person licensed |
---|
88 | 161 | | or regulated by an agency listed in Subsection (a)(1), the board |
---|
89 | 162 | | [director] shall notify that agency of the disclosure of the |
---|
90 | 163 | | information not later than the 10th working day after the date the |
---|
91 | 164 | | information is disclosed. |
---|
92 | 165 | | (h) If the board [director] withholds notification to an |
---|
93 | 166 | | agency under Subsection (f), the board [director] shall notify the |
---|
94 | 167 | | agency of the disclosure of the information and the reason for |
---|
95 | 168 | | withholding notification when the board [director] determines that |
---|
96 | 169 | | notification is no longer likely to interfere with an |
---|
97 | 170 | | administrative or criminal investigation or prosecution. |
---|
105 | 178 | | Code, is amended by adding Sections 481.0767, 481.0768, and |
---|
106 | 179 | | 481.0769 to read as follows: |
---|
107 | 180 | | Sec. 481.0767. ADVISORY COMMITTEE. (a) The board shall |
---|
108 | 181 | | establish an advisory committee to make recommendations regarding |
---|
109 | 182 | | information submitted to the board and access to that information |
---|
110 | 183 | | under Sections 481.074, 481.075, 481.076, and 481.0761, including |
---|
111 | 184 | | recommendations for: |
---|
112 | 185 | | (1) operational improvements to the electronic system |
---|
113 | 186 | | that stores the information, including implementing best practices |
---|
114 | 187 | | and improvements that address system weaknesses and workflow |
---|
115 | 188 | | challenges; |
---|
116 | 189 | | (2) resolutions to identified data concerns; |
---|
117 | 190 | | (3) methods to improve data accuracy, integrity, and |
---|
118 | 191 | | security and to reduce technical difficulties; and |
---|
119 | 192 | | (4) the addition of any new data set or service to the |
---|
120 | 193 | | information submitted to the board or the access to that |
---|
121 | 194 | | information. |
---|
122 | 195 | | (b) The board shall appoint the following members to the |
---|
123 | 196 | | advisory committee: |
---|
124 | 197 | | (1) a physician licensed in this state who practices |
---|
125 | 198 | | in pain management; |
---|
126 | 199 | | (2) a physician licensed in this state who practices |
---|
127 | 200 | | in family medicine; |
---|
128 | 201 | | (3) a physician licensed in this state who performs |
---|
129 | 202 | | surgery; |
---|
130 | 203 | | (4) a physician licensed in this state who practices |
---|
131 | 204 | | in emergency medicine at a hospital; |
---|
132 | 205 | | (5) a physician licensed in this state who practices |
---|
133 | 206 | | in psychiatry; |
---|
134 | 207 | | (6) an oral and maxillofacial surgeon; |
---|
135 | 208 | | (7) a physician assistant or advanced practice |
---|
136 | 209 | | registered nurse to whom a physician has delegated the authority to |
---|
137 | 210 | | prescribe or order a drug; |
---|
138 | 211 | | (8) a pharmacist working at a chain pharmacy; |
---|
139 | 212 | | (9) a pharmacist working at an independent pharmacy; |
---|
140 | 213 | | (10) an academic pharmacist; and |
---|
141 | 214 | | (11) two representatives of the health information |
---|
142 | 215 | | technology industry, at least one of whom is a representative of a |
---|
143 | 216 | | company whose primary line of business is electronic medical |
---|
144 | 217 | | records. |
---|
145 | 218 | | (c) Members of the advisory committee serve three-year |
---|
146 | 219 | | terms. Each member shall serve until the member's replacement has |
---|
147 | 220 | | been appointed. |
---|
148 | 221 | | (d) The advisory committee shall annually elect a presiding |
---|
149 | 222 | | officer from its members. |
---|
150 | 223 | | (e) The advisory committee shall meet at least two times a |
---|
151 | 224 | | year and at the call of the presiding officer or the board. |
---|
152 | 225 | | (f) A member of the advisory committee serves without |
---|
153 | 226 | | compensation but may be reimbursed by the board for actual expenses |
---|
154 | 227 | | incurred in performing the duties of the advisory committee. |
---|
155 | 228 | | Sec. 481.0768. ADMINISTRATIVE PENALTY: DISCLOSURE OR USE |
---|
156 | 229 | | OF INFORMATION. (a) A person authorized to receive information |
---|
157 | 230 | | under Section 481.076(a) may not disclose or use the information in |
---|
158 | 231 | | a manner not authorized by this subchapter or other law. |
---|
159 | 232 | | (b) A regulatory agency that issues a license, |
---|
160 | 233 | | certification, or registration to a prescriber or dispenser shall |
---|
161 | 234 | | periodically update the administrative penalties, or any |
---|
162 | 235 | | applicable disciplinary guidelines concerning the penalties, |
---|
163 | 236 | | assessed by that agency for conduct that violates Subsection (a). |
---|
164 | 237 | | (c) The agency shall set the penalties in an amount |
---|
165 | 238 | | sufficient to deter the conduct. |
---|
166 | 239 | | Sec. 481.0769. CRIMINAL OFFENSES RELATED TO PRESCRIPTION |
---|
167 | 240 | | INFORMATION. (a) A person authorized to receive information under |
---|
168 | 241 | | Section 481.076(a) commits an offense if the person discloses or |
---|
169 | 242 | | uses the information in a manner not authorized by this subchapter |
---|
170 | 243 | | or other law. |
---|
171 | 244 | | (b) A person requesting information under Section |
---|
172 | 245 | | 481.076(a-6) commits an offense if the person makes a material |
---|
173 | 246 | | misrepresentation or fails to disclose a material fact in the |
---|
174 | 247 | | request for information under that subsection. |
---|
175 | 248 | | (c) An offense under Subsection (a) is a Class A |
---|
176 | 249 | | misdemeanor. |
---|
177 | 250 | | (d) An offense under Subsection (b) is a Class C |
---|
178 | 251 | | misdemeanor. |
---|
189 | | - | 481.076, 481.0761, 481.0762, 481.0763, 481.0764, 481.0765, [and] |
---|
190 | | - | 481.0766, 481.0767, 481.0768, and 481.0769. The board may adopt |
---|
191 | | - | rules to administer Sections 481.073, 481.074, 481.075, 481.076, |
---|
192 | | - | 481.0761, 481.0762, 481.0763, 481.0764, 481.0765, [and] 481.0766, |
---|
193 | | - | 481.0767, 481.0768, and 481.0769. |
---|
194 | | - | SECTION 6. Section 481.128(a), Health and Safety Code, is |
---|
| 262 | + | 481.0755, 481.076, 481.0761, 481.0762, 481.0763, 481.0764, |
---|
| 263 | + | 481.0765, [and] 481.0766, 481.0767, 481.0768, and 481.0769. The |
---|
| 264 | + | board may adopt rules to administer Sections 481.073, 481.074, |
---|
| 265 | + | 481.075, 481.0755, 481.076, 481.0761, 481.0762, 481.0763, |
---|
| 266 | + | 481.0764, 481.0765, [and] 481.0766, 481.0767, 481.0768, and |
---|
| 267 | + | 481.0769. |
---|
| 268 | + | SECTION 7. Section 481.128(a), Health and Safety Code, is |
---|
195 | 269 | | amended to read as follows: |
---|
196 | 270 | | (a) A registrant or dispenser commits an offense if the |
---|
197 | 271 | | registrant or dispenser knowingly: |
---|
198 | 272 | | (1) distributes, delivers, administers, or dispenses |
---|
199 | 273 | | a controlled substance in violation of Subchapter C [Sections |
---|
200 | 274 | | 481.070-481.075]; |
---|
201 | 275 | | (2) manufactures a controlled substance not |
---|
202 | 276 | | authorized by the person's Federal Drug Enforcement Administration |
---|
203 | 277 | | registration or distributes or dispenses a controlled substance not |
---|
204 | 278 | | authorized by the person's registration to another registrant or |
---|
205 | 279 | | other person; |
---|
206 | 280 | | (3) refuses or fails to make, keep, or furnish a |
---|
207 | 281 | | record, report, notification, order form, statement, invoice, or |
---|
208 | 282 | | information required by this chapter; |
---|
209 | 283 | | (4) prints, manufactures, possesses, or produces an |
---|
210 | 284 | | official prescription form without the approval of the board; |
---|
211 | 285 | | (5) delivers or possesses a counterfeit official |
---|
212 | 286 | | prescription form; |
---|
213 | 287 | | (6) refuses an entry into a premise for an inspection |
---|
214 | 288 | | authorized by this chapter; |
---|
215 | 289 | | (7) refuses or fails to return an official |
---|
216 | 290 | | prescription form as required by Section 481.075(k); |
---|
217 | 291 | | (8) refuses or fails to make, keep, or furnish a |
---|
218 | 292 | | record, report, notification, order form, statement, invoice, or |
---|
219 | 293 | | information required by a rule adopted by the director or the board; |
---|
220 | 294 | | or |
---|
221 | 295 | | (9) refuses or fails to maintain security required by |
---|
222 | 296 | | this chapter or a rule adopted under this chapter. |
---|
224 | 298 | | amended to read as follows: |
---|
225 | 299 | | (a) A person commits an offense if the person knowingly: |
---|
226 | 300 | | (1) distributes as a registrant or dispenser a |
---|
227 | 301 | | controlled substance listed in Schedule I or II, unless the person |
---|
228 | 302 | | distributes the controlled substance as authorized under the |
---|
229 | 303 | | federal Controlled Substances Act (21 U.S.C. Section 801 et seq.); |
---|
230 | 304 | | (2) uses in the course of manufacturing, prescribing, |
---|
231 | 305 | | or distributing a controlled substance a Federal Drug Enforcement |
---|
232 | 306 | | Administration registration number that is fictitious, revoked, |
---|
233 | 307 | | suspended, or issued to another person; |
---|
234 | 308 | | (3) issues a prescription bearing a forged or |
---|
235 | 309 | | fictitious signature; |
---|
236 | 310 | | (4) uses a prescription issued to another person to |
---|
237 | 311 | | prescribe a Schedule II controlled substance; |
---|
238 | 312 | | (5) possesses, obtains, or attempts to possess or |
---|
239 | 313 | | obtain a controlled substance or an increased quantity of a |
---|
240 | 314 | | controlled substance: |
---|
241 | 315 | | (A) by misrepresentation, fraud, forgery, |
---|
242 | 316 | | deception, or subterfuge; |
---|
243 | 317 | | (B) through use of a fraudulent prescription |
---|
244 | 318 | | form; [or] |
---|
245 | 319 | | (C) through use of a fraudulent oral or |
---|
246 | 320 | | telephonically communicated prescription; or |
---|
247 | 321 | | (D) through the use of a fraudulent electronic |
---|
248 | 322 | | prescription; or |
---|
249 | 323 | | (6) furnishes false or fraudulent material |
---|
250 | 324 | | information in or omits material information from an application, |
---|
251 | 325 | | report, record, or other document required to be kept or filed under |
---|
252 | 326 | | this chapter. |
---|
256 | | - | 481.073, 481.074, 481.075, 481.076, 481.0761, 481.0762, 481.0763, |
---|
257 | | - | 481.0764, 481.0765, [and] 481.0766, 481.0767, 481.0768, and |
---|
258 | | - | 481.0769, Health and Safety Code. |
---|
259 | | - | SECTION 9. Section 565.003, Occupations Code, is amended to |
---|
260 | | - | read as follows: |
---|
| 330 | + | 481.073, 481.074, 481.075, 481.0755, 481.076, 481.0761, 481.0762, |
---|
| 331 | + | 481.0763, 481.0764, 481.0765, [and] 481.0766, 481.0767, 481.0768, |
---|
| 332 | + | and 481.0769, Health and Safety Code. |
---|
| 333 | + | SECTION 10. Section 565.003, Occupations Code, is amended |
---|
| 334 | + | to read as follows: |
---|
308 | | - | SECTION 15. This Act takes effect September 1, 2019. |
---|
309 | | - | ______________________________ ______________________________ |
---|
310 | | - | President of the Senate Speaker of the House |
---|
311 | | - | I certify that H.B. No. 3284 was passed by the House on May |
---|
312 | | - | 10, 2019, by the following vote: Yeas 136, Nays 3, 1 present, not |
---|
313 | | - | voting; that the House refused to concur in Senate amendments to |
---|
314 | | - | H.B. No. 3284 on May 24, 2019, and requested the appointment of a |
---|
315 | | - | conference committee to consider the differences between the two |
---|
316 | | - | houses; and that the House adopted the conference committee report |
---|
317 | | - | on H.B. No. 3284 on May 26, 2019, by the following vote: Yeas 139, |
---|
318 | | - | Nays 4, 1 present, not voting. |
---|
319 | | - | ______________________________ |
---|
320 | | - | Chief Clerk of the House |
---|
321 | | - | I certify that H.B. No. 3284 was passed by the Senate, with |
---|
322 | | - | amendments, on May 22, 2019, by the following vote: Yeas 30, Nays |
---|
323 | | - | 1; at the request of the House, the Senate appointed a conference |
---|
324 | | - | committee to consider the differences between the two houses; and |
---|
325 | | - | that the Senate adopted the conference committee report on H.B. No. |
---|
326 | | - | 3284 on May 26, 2019, by the following vote: Yeas 30, Nays 1. |
---|
327 | | - | ______________________________ |
---|
328 | | - | Secretary of the Senate |
---|
329 | | - | APPROVED: __________________ |
---|
330 | | - | Date |
---|
331 | | - | __________________ |
---|
332 | | - | Governor |
---|
| 385 | + | SECTION 17. This Act takes effect September 1, 2019. |
---|
| 386 | + | * * * * * |
---|